policy
ACAP Submits Comments on Medicare Prescription Payment Plan Guidance (Part 2)
On March 16, ACAP submitted its comment letter to CMS on the Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025.
ACAP chose to respond to this draft guidance in support of the Medicare Prescription Payment Plan’s overarching goals and suggested approaches; but with several requests to ensure that this program will be appropriately targeted to those who would benefit the most.
These requests include comments on the following:
- Concerns about Impacts on the LIS/Duals Population
- Model Materials
- Web-based Applications
- Member ID Care Mailings
- Requirements for Identifying Enrollees Likely to Benefit Prior to the Plan Year
- Quality Measures
- Program Monitoring
- Operational Flexibility
Read the comment letter in full, including expanded comments, via the sidebar on the right.